Members of the House of Representatives propose fast-track legalization to change the rules for cannabis research On July 26, the
FDA
Cannabis Administration and Opportunities Act (ACT) would remove cannabis from federal list of controlled substances Three Major U.S. Democratic Senators
FDA approves Epidiolex for genetic syndrome of tuberous sclerosis New FDA approval, granted July 31 in the United States, validates
FDA Says Path to Cannabis Product Approval Involves Clinical Trials The U.S. Food and Drug Administration on Tuesday released
In the absence of FDA regulations, products containing CBD oil are banned for pilots, the US Air Force said Tuesday.
Tests show contaminant in cannabis-based vaping products linked to lung disease US Centers
FDA doesn't have the luxury of waiting The Food and Drug Administration (FDA) held a hearing on May 31 to seek comments from
The FDA holds its first CBD hearing in May, as the agency plans to legalize the compound in food and beverages.
CBD-based productions are considered illegal by the FDA, while the cultivation of hemp is now authorized in the United States. Industry
If Epidiolex receives approval from US authorities, this cannabidiol drug could reform US federal law. Epidiolex, a derivative drug